4 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
the Preventive Treatment ... End Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
the Preventive Treatment ... Trial Group #EBM #Neuro ... #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
the Preventive Treatment ... End Points #EBM #Neuro ... #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... Electrodiagnostic studies (Ex EMG ... and cauda equina TREATMENT ... Hospital of Baltimore IM ... GBS #Guillain #Barre